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Summary  Staphylococcus  aureus  continues  to  pose  major  public  health  challenges
in  many  areas  because  of  antibiotic  resistance  problems.  In  the  Caribbean,  especially
Trinidad  and  Tobago,  the  challenge  is  not  different.  This  study  was  performed  to
evaluate  the  antimicrobial  resistance  gene  prevalence  among  S.  aureus  isolates  in
Trinidad  and  Tobago.
Standard  and  molecular  microbiological  methods,  including  the  Microscan  auto-
mated  system,  DNA  microarray  and  multi  locus  sequence  typing  (MLST)  analysis,
were  performed  on  309  clinical  S.  aureus  isolates  recovered  from  patients  who  were
treated  at  three  of  the  country’s  main  health  institutions.
S.  aureus  exhibited  susceptibilities  ≥80%  to  eleven  of  the  19  antimicrobials  tested
against  it,  and  these  belong  to  the  most  commonly  used  and  available  antibiotics  in
the  country.  While  the  antibiotic  to  which  it  was  most  susceptible  of  the  commonly
used  antibiotics  was  trimethoprim/sulfamethoxazole,  the  antibiotics  to  which  it  was
least  susceptible  or  most  resistant  to  were  ampicillin  and  penicillin.  S.  aureus  iso-
c  ward  produced  the  greatest  rate  of  susceptibility  among  thelates  from  the  pediatriPlease  cite  this  article  in  press  as:  Akpaka  PE,  et  al.  Molecular  characterization  of  antimicrobial  resis-
tance  genes  against  Staphylococcus  aureus  isolates  from  Trinidad  and  Tobago.  J  Infect  Public  Health  (2016),
http://dx.doi.org/10.1016/j.jiph.2016.05.010
isolates  recovered  from  patients  admitted  into  hospitals,  while  isolates  from  Acci-
dent  and  Emergency  rooms  displayed  the  greatest  susceptibilities  among  patients
from  the  community.
∗ Corresponding author. Tel.: +1 868 736 0440; fax: +1 868 663 3797.
E-mail address: peakpaka@yahoo.co.uk (P.E. Akpaka).
ttp://dx.doi.org/10.1016/j.jiph.2016.05.010
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ARTICLE IN PRESSJIPH-593; No. of Pages 8
2  P.E.  Akpaka  et  al.
S.  aureus  isolates  from  the  country  did  not  harbor  acquired  resistant  genes  targeting
clindamycin/macrolides  (ermB), linezolid  (cfr)  or  vancomycin  (vanA). The  blaZ  gene,
which  is  the  most  common  beta  lactam  (Penicillinase)  resistance  mechanism  for  S.
aureus,  was  observed  in  88.7%  of  the  methicillin  susceptible  S.  aureus, while  methi-
cillin  resistance  mediated  by  the  mec  gene  was  present  in  13.6%.  Most  of  the  resistance
markers  found  in  MRSA  isolates  were  signiﬁcantly  associated  with  the  ST239-MRSA-
III  strain  in  this  study,  and  all  isolates  that  belonged  to  the  USA300  strain,  which
additionally  encoded  both  the  PVL  gene  and  ACME  cluster,  belonged  to  CC8.
Several  resistant  genes,  such  as  vanA, cfr  and  ermB, mediating  resistance  in  S.
aureus,  are  currently  non-existent  in  Trinidad  and  Tobago.  However,  the  major-
ere  observed,  suggesting  that  there  is  ongoing  nosocomial
al  community  transmission.  This  calls  for  stringent  antibiotic
 in  the  country.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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admitted  into  the  hospitals  and  those  coming
directly from  communities  in  Trinidad  and  Tobago
over a 10-month  period  in  2011—2012.  The  studyity  of  SCCmec  genes  w
transmission  with  minim
stewardship  and  policies
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Introduction
Severe  S.  aureus  infections  require  combative
treatment, including  incision  and  drainage  for
abscesses  and  systematic  antibiotics  [1].  System-
atic antibiotics  are  necessary  for  deep-seated  and
systematic  infections  [2]. In  the  1940s,  penicillin,
a widely  used  antibiotic  derived  from  Penicillium
fungi, was  introduced  for  use  [3].  Penicillin  proved
to be  an  effective  antibiotic  as  it  decreased  the
incidence  and  spread  of  infections  as  well  as  deaths
caused  by  S.  aureus.  Penicillin  acts  by  preventing
cell wall  formation  as  it  competes  for  protein  bind-
ing sites  on  the  bacterium.  However,  resistance  to
penicillin was  observed  in  the  late  1940s  with  the
emergence  of  the  enzyme  penicillinase,  which  inac-
tivates penicillin  [3]. Treating  penicillin-resistant  S.
aureus led  to  the  synthesis  and  further  introduc-
tion of  methicillin  in  1959  [4]. However,  in  1961,
there were  reports  from  the  United  Kingdom  of
methicillin-resistant  S.  aureus  (MRSA).  This  trend
was similarly  seen  in  other  European  countries,
Japan, the  United  States  of  America  and  Australia
[4].  In  the  subsequent  years,  resistance  developed
to a  range  of  antibiotics,  including  macrolides,  ﬂu-
oroquinolones,  aminoglycosides,  glycopeptides  and
tetracyclines.
Phenotypic  methods  have  been  used  to  iden-
tify and  susceptibility  test  S.  aureus  isolates  in
many studies,  and  data  on  the  characterization
of S.  aureus  using  molecular  methods  are  limited
in most  undeveloped  countries  [5,6].  Knowledge
of S.  aureus  susceptibility  patterns  and  molecular
characterization  of  genes  mediating  resistance  are
very important  for  developing  effective  infectionPlease  cite  this  article  in  press  as:  Akpaka  PE,  et  al
tance  genes  against  Staphylococcus  aureus  isolates  from  
http://dx.doi.org/10.1016/j.jiph.2016.05.010
control measures  and  treating  or  combating  staphy-
lococcal  infections  [5,6].
w
hMany  staphylococcal  strains  are  known  to  resist
ultiple antibiotics  and  exhibit  reduced  suscep-
ibility  to  glycopeptides,  such  as  vancomycin.
owever, with  the  rise  of  glycopeptide  interme-
iate susceptible  S.  aureus  (GISA)  and  resistant
enes, such  as  vanA,  there  is  a great  concern  in
dministering  treatment  [7—9].  Alternatively,  other
rugs have  been  used,  such  as  linezolid,  whose
esistance is  uncommon  and  encoded  for  by the
fr gene  [8,9]. Several  other  genes  are  responsible
or antibiotic  resistance  in  S.  aureus.  For  exam-
le, macrolide/clindamycin  resistance  is  encoded
y the  erm  gene,  while  the  aphA3  and  sat  genes
onfer resistance  to  neo-/kanamycin  and  strepto-
ycin,  respectively.  Gentamycin  and  tobramycin
esistance are  encoded  for  by  the  accA-aphD genes
nd tetracycline  resistance  is  carried  on  the  tet
enes [8,9]. In  an  era  of  rapid  antimicrobial  resis-
ance gene  spread  on  multi  resistance  plasmids,  our
ain objective  was  to  evaluate  and  document  the
enes encoding  antibiotic  resistance  in  S.  aureus
solates recovered  from  several  major  hospitals  in
rinidad and  Tobago.
aterials and methods
his  was  an  observational  cross-sectional  study
o investigate  the  susceptibility  proﬁles  of  sev-
ral antimicrobial  agents  on  S.  aureus  isolates
ncountered in  several  infection  types  for  patients.  Molecular  characterization  of  antimicrobial  resis-
Trinidad  and  Tobago.  J  Infect  Public  Health  (2016),
as conducted  at  three  of  the  ﬁve  major  regional
ospitals across  the  country.  Ethical  approval  for
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revalent  antibiotic  resistant  genes  in  Staphylococc
his  study  was  granted  by  the  Ethics  Committee,
he University  of  the  West  Indies,  St.  Augustine  and
ritten permissions  were  obtained  from  the  health
are facilities  where  samples  were  collected.
acterial isolates and susceptibility tests
taphylococcus  aureus  isolates  used  for  the  anal-
sis were  previously  reported  [10—12].  Antibiotic
usceptibility  testing  was  performed  using  conven-
ional,  automated  (Microscan  Walkaway,  Siemens
SA)  and  molecular  methods  (DNA  Microarray  assay
nd Multi  Locus  Sequence  Type  —  MLST).  The
inimum inhibitory  concentrations  (MIC)  of  the
ntimicrobial  agents  were  measured  using  the
alkaway  system.  The  conventional  disk  diffu-
ion method  with  antibiotic  disks  (Oxoid)  was
sed to  determine  the  susceptibility  proﬁles  of  all
solates to  ampicillin,  amoxicillin,  ciproﬂoxacin,
rythromycin,  gentamicin,  levoﬂoxacin,  oxacillin,
ifampin,  trimethoprim-sulfamethoxazole  (TMP-
MX), tetracycline  and  vancomycin  in  accordance
ith the  Clinical  and  Laboratory  Standard  Institute
CLSI)  guidelines  [13]. The  minimum  inhibitory  con-
entrations  (MIC)  determined  using  the  Microscan
ystem (Panel  for  Gram  positive  organisms)  were
nalyzed  for  all  of  the  above  agents,  including  line-
olid, nitrofurantoin,  clindamycin,  chlorampheni-
ol, penicillin,  rifampin,  quinupristin/dalfopristin,
etracycline,  trimethoprim/sulfamethaoxazole  and
ancomycin.  The  zone  sizes  of  the  disc  diffusion
ethod and  MIC  were  interpreted  according  to  CLSI
reakpoints  [13]. American  Type  Culture  Collection
. aureus  strains  ATCC  29213;  25923  and  S.  epider-
idis  ATCC  12228  were  used  as  quality  controls.
olecular analysis
urther  S.  aureus  identiﬁcation  and  molecular
nalysis were  performed  using  DNA  Microarray  at
nstitute  for  Medical  Microbiology  and  Hygiene,
edizinische Fakultaet  Carl  Gustav  Carus,  Fiedler-
tr Dresden,  Germany.  The  S.  aureus  Genotyping  kit
Alere Technologies  GmbH,  Germany)  was  utilized,
hich  allows  for  DNA-based  detection  of  resistance
enes, pathogenicity  markers  of  S.  aureus  and
ssignment  of  unknown  isolates  to  known  strains.
he principle  of  the  procedure  is  that  40-fold  ampli-
cation  of  clonal  S.  aureus,  which  is  labeled  with
iotin-dUTP, has  similarities  to  the  linear  PCR  pro-
ocol. Multi-Locus  Sequence  Typing  for  S.  aureus
eveloped by  Mark  Enright  [14]  and  the  correspond-Please  cite  this  article  in  press  as:  Akpaka  PE,  et  al
tance  genes  against  Staphylococcus  aureus  isolates  from  
http://dx.doi.org/10.1016/j.jiph.2016.05.010
ng database  of  allelic  proﬁles  for  over  1000  isolates
ith approximately  3000  sequence  types  from  inva-
ive diseases  in  several  areas  were  utilized.  The
llelic proﬁle  of  a  S.  aureus  strain  is  attained  by
e
s
t
t PRESS
ureus  isolates  from  Trinidad  and  Tobago  3
nternal  fragments  of  seven  housekeeping  genes
hat are  sequenced.  Statistical  Package  for  the
ocial Sciences  (SPSS)  version  20  was  used  to  ana-
yze the  data.  The  chi-squared  and  Fisher’s  exact
ests were  used,  as  appropriate,  to  compare  data
rom different  groups.  The  data  were  descriptive
nd were  reported  as  comparisons  of  the  frequency
istributions. P values  <0.05  were  considered  sta-
istically  signiﬁcant.
esults
he  S.  aureus  isolates  (n  =  309)  included  in  this
nalysis  were  from  a previously  reported  study
12]. The  antimicrobial  patterns  were  analyzed  and
he genes  were  detected  by  DNA  hybridization.
wo hundred  and  sixty-seven  isolates  (267/309,
6.4%) were  methicillin  sensitive  S.  aureus,  while
orty-two  (42/309;  13.6%)  were  MRSA  and  the  dif-
erence  between  these  were  statistically  signiﬁcant
P <  0.05).
A  high  incidence  of  susceptibility  was  observed
mong most  of  the  isolates  from  each  infection  to
he 19  antibiotic  drugs  tested,  as  shown  in  Table  1
here  S.  aureus  isolates  were  80%  susceptible  to
leven of  the  antibiotics  commonly  available  and
sed in  the  country.
Staphylococcus  aureus  were  92.9%  susceptibil-
ty to  trimethoprim/sulfamethoxazole,  which  is  one
f the  antibiotics  available  and  used  in  the  coun-
ry, with  an  MIC  value  of  <2/38  g/ml.  The  isolates
ere least  susceptible  to  ampicillin  (10.7%)  and
enicillin  (11.7%)  despite  having  very  low  MIC  with
alues of  <0.25  g/ml  and  <0.12  g/ml,  respec-
ively. Among  the  methicillin  susceptible  S.  aureus
solates, the  susceptibility  rates  were  high  to
mipenem (85%),  trimethoprim/sulfamethoxazole
84%) and  cephalothin  (84%).  One  hundred  percent
100%) of  MRSA  isolates  were  resistant  to  ampicillin
nd penicillin,  while  the  isolates  were  1—2%  sus-
eptible  to  oxacillin,  amoxicillin/clavulanate  and
rythromycin  and  produced  low  susceptibility  rates
hat were  below  10%  to  several  other  antibiotics,
uch as  gentamicin  and  clindamycin.
There was  a statistically  signiﬁcant  difference
etween susceptibility  of  MSSA  and  MRSA  isolates
o all  antibiotics  (P  <  0.05).
Of the  309  S.  aureus  tested,  124  (40.1%)  were
esistant to  erythromycin,  while  111(36%)  were
esistant  to  clindamycin.  The  MIC  values  for  both.  Molecular  characterization  of  antimicrobial  resis-
Trinidad  and  Tobago.  J  Infect  Public  Health  (2016),
rythromycin  and  clindamycin  among  the  MSSA
trains were  ≤0.5  g/ml.  The  MRSA  strains  resistant
o macrolides  or  macrolides/lincosamides  harbored
he ermA  (n  =  20),  ermC  (n  = 2)  and  msrA  (n  =  17)
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Table  1  The  MIC  values  and  susceptibility  percentages  of  MSSA  and  MRSA  isolates  (n).
Antibiotics  Resistant  Sensitive  Sensitive  isolates
Mic  g/ml  MSSA  MRSA
Amox/Clavu  21  (65)  79  (244)  ≤4/2  77  2
Ampicillin  89.3  (276) 10.7  (33) ≤0.25  11  0
Cephalothin  11.3  (35) 88.7  (274) ≤8 84  5
Chloramphenicol  43  (133)  57  (176)  ≤8  49  8
Ciproﬂoxacin  16.8  (52)  83.2  (257)  ≤1  80  3
Clindamycin  36  (111)  4  (198)  ≤0.5  58  6
Erythromycin  40.1  (124)  59.9  (185)  ≤0.5  67  2
Gentamicin  25.2  (78)  74.8  (231)  ≤4  68  7
Imipenem  10.4  (32)  89.6  (277)  ≤4  85  5
Levoﬂoxacin  19.4  (60)  80.6  (249)  ≤1  78  3
Linezolid  19.1  (59)  80.9  (250)  ≤4  69  12
Nitrofurantoin  0.3  (1)  99.7  (308)  ≤32  86  14
Oxacillin  15.2  (47)  84.8  (262)  ≤2  84  1
Penicillin  88.3  (273)  11.7  (36)  ≤0.12  11  0
Rifampin  6.5  (20)  93.5  (289)  ≤1  81  13
Quinu/Dalfo  28.8  (89)  71.2  (220)  ≤1  61  10
Tetracycline  13.9  (43)  86  (266)  ≤4  80  6
Trime/Sulfa  7.1  (22)  92.9  (287)  ≤2/38  84  8
Vancomycin  19.1  (59)  0.9  (250)  ≤2  70  11
MIC = minimum inhibitory concentration values; MSSA = methicillin sensitive S. aureus;  MRSA = methicillin resistant S.
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Daureus; Resist = resistant isolates; Amox/Clavul = amoxicillin/c
trimethoprim/sulfamethaoxazole.
genes.  The  genes  associated  with  antibiotic  resis-
tance in  both  MSSA  and  MRSA  isolates  in  this  study
are outlined  in  Table  2. In  this  analysis,  Staphy-
lococcal cassette  chromosome  mec  (SCCmec),  one
of the  MRSA  resistance  islands,  was  encountered.
Types I  and  IV  only  occurred  in  2 isolates  each,
while Types  II  and  III  were  encountered  in  17  and  21
isolates,  respectively.  The  blaZ  gene,  which  is  the
most common  resistance  mechanism  of  S.  aureus
to beta  lactams  (Penicillinase),  was  observed  in
88.7% (274/309)  of  the  isolates  (MRSA  42/309  and
MSSA 233/309).  Of  interest  is  that,  in  Trinidad
and Tobago,  the  acquired  resistance  genes  were
normally  located  on  the  plasmid  or  chromosome
targeting macrolides/clindamycin  (erm(B)),  line-
zolid (cfr),  vancomycin  (vanA)  in  S.  aureus  and  none
of the  MRSA  and  MSSA  harbored  erm(B)  or  mef(A)
genes.
However,  among  MRSA  isolates,  the  following
genes were  observed:  mecA,  SCCmec  II,  SCCmec  III
— 0%  in  MSSA;  42%,  17%,  and  21%  in  MRSA,  target-
ing beta  lactam  antibiotics;  erm(A)  —  1%  in  MSSA
and 48%  MRSA,  generally  targeting  macrolides  and
lincosamides;  aacA-aphD  —  0%  in  MSSA  and  20%  in
MRSA, targeting  aminoglycosides  like  gentamicin;Please  cite  this  article  in  press  as:  Akpaka  PE,  et  al
tance  genes  against  Staphylococcus  aureus  isolates  from  
http://dx.doi.org/10.1016/j.jiph.2016.05.010
tet(K) —  2%  in  MSSA  and  45%  in  MRSA;  and  tet(M)
— 2%  in  MSSA  and  48%  in  MRSA,  targeting  tetracy-
cline. All  differed  signiﬁcantly  when  compared  with
the MSSA  isolates  (p-value  <0.05).  The  resistance
S
c
panate; Quinu/Dalfo = quinupristin/dalfopristin; Trime/Sulfa =
arkers  commonly  found  in  the  MRSA  isolates
ere, in  the  current  study,  signiﬁcantly  associated
ith the  ST239-MRSA-III  strain.  Common  resistance
enes,  msr  (2%  in  MSSA  and  40%  in  MRSA)  and
ph (1%  in  MSSA;  and  40%  in  MRSA)  were  also
otably associated  with  USA300.  The  2%  SCCmec  IV
bserved  in  this  analysis  occurred  in  the  MRSA  iso-
ates recovered  from  patients  who  were  from  the
ommunity  areas  in  the  country.
The mecA  positive  (13.6%,  42/309)  isolates  were
pread  over  the  following  three  lineages:  CC5,
C8 and  CC59  (data  not  shown).  Clonal  complex
 accounted  for  2%  (1/42)  of  MRSA  isolates,  while
C8 contributed  seven  sequence  types  to  the  MRSA
roup,  accounting  for  93%  (39/42)  of  the  MRSA  iso-
ates. The  most  common  SCCmec  type  was  SCCmec
II (21  isolates)  for  which  all  isolates  belonged  to
T239. These  isolates  also  encoded  merA/B  genes,
hich are  likely  to  indicate  a  presence  of  a compos-
te SCCmec  III/SCCmer  element.  Seventeen  isolates
elonged  to  the  CC8  USA300  strain  and  additionally
ncoded both  the  PVL  genes  and  ACME  cluster.
iscussions.  Molecular  characterization  of  antimicrobial  resis-
Trinidad  and  Tobago.  J  Infect  Public  Health  (2016),
usceptibility  patterns  of  S.  aureus  strains  differ
onsiderably  in  different  regions.  Ampicillin  and
enicillin  remain  the  least  efﬁcient  antibiotics  as
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Table  2  Genes  associated  with  antibiotic  resistance  among  the  MSSA  and  MRSA  isolates  in  Trinidad  and  Tobago.
Gene  Gene  name  N  MSSA  MRSA
mecA Alternate  penicillin  binding  protein  2,  deﬁning  MRSA  42  0  42
SCCmec  I  Cassette  Chromosome  mec  I  2  0  2
SCCmec  II  Cassette  Chromosome  mec  II  17  0  17
SCCmec  III  Cassette  Chromosome  mec  III  21  0  21
SCCmec  IV  Cassette  Chromosome  mec  IV  2  0  2
merA/B  Mercury  resistance  operon  21  0  21
blaZ/I/R  Beta-lactamase  operon  274  233  41
erm(A) Methyltransferases,  erythromycin,  clindamycin  resistance 23  3  20
erm(B) Methyltransferases,  erythromycin,  clindamycin  resistance 0  0  0
erm(C) Methyltransferases,  erythromycin,  clindamycin  resistance 2  0  2
Inu(A) Lincosamid-Nucleotidyltransferase  1  1  0
mef(A)  Macrolide  efﬂux  protein  A  0  0  0
mph(C)  Probable  lysyphosphatidylglycerol  synthetase  20  3  17
msr(A)  Energy  dependent  efﬂux  of  erythromycin  22  5  17
aacA-aphD  Bifunctional  enzyme  Aac/Aph,  gentamicin  resistance  20  0  20
aadD  Aminoglycoside  adenyltransferase,  tobramycin  resistance  12  8  4
fusB  Fusidic  acid  resistance  gene  1  1  0
fusC  Fusidic  acid  resistance  gene  from  ‘‘SCCfus’’  elements  6  3  3
mupA  Mupirocin  resistance  protein  15  11  4
tet(K)  Tetracycline  resistance  24  5  19
tet(M)  Tetracycline  resistance  25  5  20
cat  Chloramphenicol  acetyltransferase  1  0  1
fexA  Chloramphenicol/ﬂorfenicol  exporter  0  0  0
cfr  Linezolid  resistance  0  0  0
dfrS1  Dihydrofolate  reductase  type  1  11  0
qacA Quaternary  ammonium  compound  resistance  protein  A  14  2  12
qacC  Quaternary  ammonium  compound  resistance  protein  C  7  5  2
sat  Streptothricine-acetyltransferase  39  3  36
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ivanA  Vancomycin  resistance  gene  
hey  are  older  -lactams  and  are  now  ineffective
ntibiotics in  the  treatment  and  control  of  more
han 80%  of  S.  aureus  infections  in  the  country
15].  Trimethoprim/sulfamethaoxazole,  imipenem,
ephalothin  and  oxacillin  are  among  the  antibi-
tics with  the  highest  sensitivity  rates  in  MSSA
solates, but  the  MRSA  isolates  were  highly  resistant
o oxacillin  as  expected.  A  signiﬁcant  difference
etween MSSA  and  MRSA  isolates  was  observed,
hich further  suggests  that  certain  antibiotics  are
ore effective  in  treating  either  MSSA  or  MRSA
nfections in  the  country.
The  results  of  molecular  typing  showed  that
ver 90%  of  MRSA  in  the  country  belonged  to
CCmec types  II  and  III  isolates,  while  types  I and
V accounted  for  less  than  10%.  Types  V,  VI  and
ther types  reported  in  the  literature  [16]  were
ot observed  in  our  analysis.  The  prevalence  of
wo types  of  SCCmec  II  and  III  among  the  MRSA
solates encountered  in  Trinidad  and  Tobago  indi-Please  cite  this  article  in  press  as:  Akpaka  PE,  et  al
tance  genes  against  Staphylococcus  aureus  isolates  from  
http://dx.doi.org/10.1016/j.jiph.2016.05.010
ates very  low  clonal  diversity.  Previous  studies
ave reported  that  S.  aureus  isolates  exhibiting
CCmec I, II  and  III  belong  to  health  care-associated
lones (HA-MRSA)  and  harbor  multiple  resistance
i
[
b0  0  0
eterminants,  while  types  IV  were  associated  with
ommunity-associated  clones  [17,18]. This  means
hat with  majority  of  SCCmec  cases  are  present  in
ealth institutions  in  the  country,  which  warrants
ore efforts  focusing  on  antibiotic  stewardship
nd infection  control  measures  in  the  health  care
acilities  because  there  is  now  very  low  clonal
iversity. It  has  also  been  reported  that  SCCmec
ype  II is  associated  with  increased  MRSA  mor-
ality [14,19], which  was  in  agreement  with  our
xperience  wherein  the  only  two  cases  of  mor-
ality belonged  to  SCCmec  type  II.  As  a  result,
here should  be  measures  to  rapidly  identify  the
RSA strains  harboring  the  SCCmec  genes.  As  has
een previously  reported  by  this  author  and  oth-
rs [20], evaluation  of the  cost  for  detecting  MRSA
rom clinical  specimens  should  now  be  reviewed
nd incorporated  into  routine  laboratory  tests  to
revent any  mortality  caused  by  missing  such  MRSA
nfections  in  the  country..  Molecular  characterization  of  antimicrobial  resis-
Trinidad  and  Tobago.  J  Infect  Public  Health  (2016),
The  vancomycin  gene  (vanA)  was  not  observed
n this  study,  which  is  similar  to  reports  from  Brazil
21]. The  vanA  resistance  gene  has  nonetheless
een reported  in  S.  aureus  isolates  in  the  USA
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cial assistance  and  to  all  of  the  technical  staff
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[22,23]  and  other  bacterial  species  in  Costa  Rica
[24].  Detection  of  the  resistance  mechanisms  and
their genetic  basis  is  an  important  reason  to  support
antibiotic  susceptibility  surveillance  in  S.  aureus.
Among resistance  markers,  however,  only  the
blaZ/I/R  was  commonly  found,  while  other  genes
had low  frequencies  or  were  not  found,  such  as
the erm(B),  mef(A),  fexA,  cfr  and  vanA  genes.
It could  be  hypothesized  that  resistance  of  S.
aureus to  these  agents  could  be  mediated  by  other
mechanisms  and  not  by  these  genes.  Both  clonal
spread  of  resistant  strains  and  horizontal  transfer
of resistance  genes  contribute  to  the  rising  global
prevalence  of  multi  resistant  bacteria,  and  hori-
zontal  transfer  enables  the  acquisition  of  multidrug
resistance by  previously  susceptible  bacteria  [25].
Non-existence  of  fexA  among  the  S.  aureus  isolates
is not  surprising  considering  that  this  gene  mediates
resistance towards  these  agents,  chloramphenicol
and ﬂorfenicol,  which  are  not  available  or  have
been withdrawn  from  local  markets  in  the  coun-
try for  over  20  years.  We  did  not  encounter  the  cfr
gene among  our  S.  aureus  isolates  despite  reports
of its  existence  in  several  countries,  including  the
USA, Mexico,  Ireland,  Spain,  Italy  and  Colombia,
where the  ﬁrst  clinical  isolate  was  documented
[26—31].  More  good  news  for  the  country  is  that
there is  no  resistance  to  fourth  and  ﬁfth  generation
cephalosporins,  such  as  cefepime  and  ceftaroline
(although we  did  not  include  these  in  our  studies),
because  they  have  not  yet  been  included  in  the
National drug  formulary  and  are  not  available  in  the
country.
The most  common  clonal  complex  in  our  study
was CC8,  accounting  for  93%  (39/42)  of  MRSA  iso-
lates in  our  analysis.  Similar  results  have  been
reported in  other  countries,  such  as  Japan  and
the USA,  where  this  complex  is  the  most  common
clone in  skin  and  soft  tissue-associated  infections,
especially among  PVL-positive  S.  aureus  [32,33].
More than  50%  of  these  MRSA  isolates  harbored  the
SCCmec  II  and  III  cassettes  and  were  positive  for  the
PVL gene,  while  six  (14.3%)  harboring  the  SCCmec
III cassette  were  PVL-negative.
Our  multi  locus  sequence  typing  analysis
revealed unique  S.  aureus  strains  with  similari-
ties to  ST2250/2277  that  belonged  to  the  newly
described species  S.  argenteus. They  were  not
observed to  carry  the  species  marker  coA  or  acces-
sory  gene  regulator.  They  do  have  these  genes,  but
they had  other,  unrecognized  alleles.  Thus,  while
we did  not  see  them,  we  cannot  say  that  they  are
absent.  They  were  mecA  negative  and  lacked  vari-
ous resistant  genes,  but  the  -lactamase  structural
gene (blaZ)  was  present.  Known  virulence  factors,Please  cite  this  article  in  press  as:  Akpaka  PE,  et  al
tance  genes  against  Staphylococcus  aureus  isolates  from  
http://dx.doi.org/10.1016/j.jiph.2016.05.010
including the  PVL  gene,  were  also  lacking. r PRESS
P.E.  Akpaka  et  al.
onclusions
espite  the  limitation  of  not  correlating  the  spe-
iﬁc antimicrobial  resistance  with  the  outcomes
f S.  aureus  infections,  this  study  highlighted  sev-
ral resistance  genes  of  S.  aureus  organisms  that
re currently  non-existent  in  Trinidad  and  Tobago,
uch as  vanA,  cfr  and  erm(B),  suggesting  that
here is  some  other  method  of  S. aureus  resis-
ance to  vancomycin,  linezolid  and  clindamycin.
he study  also  reported  a  high  prevalence  of
CCmec genes  among  S.  aureus  clones,  suggesting
n ongoing  nosocomial  transmission  and  minimal
ommunity  transmission.  This  observation  indi-
ates that  routine  rapid  detection  methods  of
RSA  strains,  as  has  been  previously  delineated,
hould now  be  implemented. Additionally,  there
hould  be  concerted  efforts  to  implement  strin-
ent  antibiotics  stewardship  and  policy  measures
n hospitals  throughout  the  country.  The  authors
ropose that  a more  detailed  molecular  epidemi-
logical population  study  should  be  performed  to
valuate correlations  with  antimicrobial  resistance,
utcomes  and  S.  aureus  infections  in  Trinidad  and
obago.
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